Lei Gong
Partner
Profile
Lei Gong has over 20 years’ Investment Banking experience. He was most recently the Managing Director and China Healthcare Head of BDA Partners. Previously, he acted as the Managing Director and China M&A head and was the Investment Banking Committee (China) member of Daiwa Securities for 7 years, where he was responsible for origination and execution of cross-border M&A and covering Chinese blue-chip clients. He has rich sector knowledge and deep relationship with global funds in the Chinese market.
He worked with many leading companies across various industries, including advising MicroPort Medical in its acquisition of Germany’s ECMO Hemovent, Chalkis health’s acquisition of French Le-cabanon, restructuring of Shanghai SVA group, China TianYin’s acquisition of Spanish Urbaser and advising Kobayashi Pharma partners in its JV with Sino Pharma.
He holds a Master degree in Finance from the Shanghai University of Finance and Economics.
Our latest transactions
Food & Beverage & Agribusiness
has invested in
Transaction details
French groupe Bel has invested in Chinese snack brand Lao Jin Mo Fang
Food & Beverage & Agribusiness
conducted market research regarding the Chinese market for its brand
Transaction details
Mars recieves advice on entering Chinese market with its subsidiary Foodspring
Food & Beverage & Agribusiness
has received advice on strategy to enter the Chinese market
Transaction details
Mont Blanc Materne has been advised on its strategy to enter the Chinese market with its new product Go Go Squeez
Consumer Goods & Retail
has been acquired by
Transaction details
European children's fashion manufacturer has been acquired by Chinese company Semir
